These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34485511)

  • 41. REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma.
    Han J; Bai Y; Wang J; Xie XL; Li AD; Ding Q; Cui ZJ; Yin J; Jiang XY; Jiang HQ
    Clin Exp Med; 2021 Aug; 21(3):479-492. PubMed ID: 33677646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD34, PCNA and CK19 expressions in AFP- hepatocellular carcinoma.
    Cui DJ; Wu Y; Wen DH
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5200-5205. PubMed ID: 30178842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
    Xie YM; Yan LN; Wei B; Guo MM; Tang CW
    Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
    Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
    Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.
    Fu RD; Qiu CH; Chen HA; Zhang ZG; Lu MQ
    Tumour Biol; 2014 Aug; 35(8):7603-10. PubMed ID: 24798975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis.
    Tian M; Yang X; Li Y; Guo S
    Med Sci Monit; 2020 Jun; 26():e923359. PubMed ID: 32573516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway.
    Zhang C; Zhang J; Wang J; Yan Y; Zhang C
    J Cell Mol Med; 2020 Dec; 24(23):13804-13812. PubMed ID: 33090723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
    Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
    Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.
    Xiaoyan F; Mingzhe LI; Long C; Chao L; Wenli LU; Zhiqiang P; Dongwei J; Peike P; Zhaoqin F; Xiaomei L
    J Tradit Chin Med; 2022 Dec; 42(6):922-931. PubMed ID: 36378050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
    Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
    Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
    Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
    Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.
    Chen K; Huang W; Huang B; Wei Y; Li B; Ge Y; Qin Y
    Genet Test Mol Biomarkers; 2013 Feb; 17(2):160-5. PubMed ID: 23237599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
    Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
    Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
    Zheng Y; Zhu M; Li M
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low miR-29c expression is a prognostic marker in hepatocellular carcinoma.
    Dong CW; Wang YX; Du FT; Ding W; Hu SY
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.